Nanoparticles as carriers for nasal vaccine delivery

被引:86
|
作者
Köping-Höggård, M [1 ]
Sánchez, A [1 ]
Alonso, MJ [1 ]
机构
[1] Sch Pharm, Dept Pharm & Pharmaceut Technol, Santiago De Compostela 15782, Spain
关键词
chitosan; DNA; mucosal; nanoparticles; nasal; PLA; PLGA; vaccine;
D O I
10.1586/14760584.4.2.185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At present, there is considerable excitement within the nanotechnology field with regard to the potential use of nanosystems as carriers for mucosal vaccine delivery. Indeed, many of the vaccines available, including protein antigens and DNA vaccines, are very unstable and need to be protected from degradation in the biologic environment. In addition, their efficacy is limited by their poor capacity to cross biologic barriers and reach the target sites. As a consequence, the design of appropriate antigen carriers that could help overcome these problems has become a significant challenge. The goal of the present article is to review the recent advances in the design of polymeric nanosystems intended to be used as carriers for nasal vaccine delivery. More specifically, the authors present nanocarriers; that have been made of safe materials, such as biodegradable polyesters and polysaccharides. The information accumulated regarding the in vivo behavior of these nanocarriers indicates that they are able to facilitate the transport of the associated antigen across the nasal epithelium, thus leading to efficient antigen presentation to the immune system. Furthermore, the results suggest that not only the size and surface properties but also the polymer composition and the structural architecture of the nanosystems are critical for the optimization of these antigen carriers. In conclusion, future studies intended to provide increased knowledge regarding these properties and how they relate to the efficiency of the immune responses, will undoubtedly affect the design of new and more effective nasal vaccine delivery strategies.
引用
收藏
页码:185 / 196
页数:12
相关论文
共 50 条
  • [11] Nanoparticles in Vaccine Delivery
    Salem, Aliasger K.
    AAPS JOURNAL, 2015, 17 (02): : 289 - 291
  • [12] Progesterone bearing mucoadhesive carriers for nasal delivery
    Jain, S. K.
    Jain, A.
    Gupta, Y.
    Gupta, U.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2007, 17 (02) : 137 - 143
  • [13] Nanoparticles: Emerging carriers for drug delivery
    Mudshinge, Sagar R.
    Deore, Amol B.
    Patil, Sachin
    Bhalgat, Chetan M.
    SAUDI PHARMACEUTICAL JOURNAL, 2011, 19 (03) : 129 - 141
  • [14] Nanoparticles as delivery carriers for anticancer prodrugs
    Fang, Jia-You
    Al-Suwayeh, Saleh A.
    EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (06) : 657 - 669
  • [15] Novel Nanocolloidal Carriers for Noninvasive Vaccine Delivery
    Beg, Sarwar
    Rahman, Mahfoozur
    Swain, Suryakanta
    Imam, Syed Sarim
    CURRENT DRUG THERAPY, 2014, 9 (03) : 159 - 165
  • [16] Lipid Nanoparticles as Carriers for Bioactive Delivery
    Dhiman, Neerupma
    Awasthi, Rajendra
    Sharma, Bhupesh
    Kharkwal, Harsha
    Kulkarni, Giriraj T.
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [17] Nanoparticles as carriers for drug delivery in cancer
    Dadwal, Ankita
    Baldi, Ashish
    Narang, Raj Kumar
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 : 295 - 305
  • [18] Vaccine delivery carriers: Insights and future perspectives
    Correia-Pinto, J. F.
    Csaba, N.
    Alonso, M. J.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 440 (01) : 27 - 38
  • [19] Nanoparticles for DNA Vaccine Delivery
    Shah, Muhammad Ali A.
    He, Nongyue
    Li, Zhiyang
    Ali, Zeeshan
    Zhang, Liming
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2014, 10 (09) : 2332 - 2349
  • [20] Nanoparticles as Adjuvants in Vaccine Delivery
    Garg, Anuj
    Dewangan, Hitesh Kumar
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2020, 37 (02): : 183 - 204